InVatin Technologies is a MedTech company developing revolutionary solutions for stroke prevention. InVatin was founded by Dr. Nussinovitch during his service as a hyperbaric physician in the Israeli Navy in order to prevent the devastating outcomes of embolic stroke in high risk patients. The company has recruited a leading team of engineers and works with experienced GLP-approved facilities in which the SYNAXIS device is being manufactured and tested.
Experienced leadership in cardiovascular medicine, clinical development and regulatory expertise in medical devices
Dr. Udi Nussinovitch
Experienced cardiology fellow. Director of the Applicative Cardiovascular Research Center, Meir Medical Center, Israel. Editor of “Emerging Technologies for Heart Diseases” (Elsevier Publishing Group). “40 under 40”, TheMarker magazine (2016)
Dr. Elon Reshef
20 years of experience in clinical and business development, R&D and research from a range of medical device companies including BioSense Webster, MindGuard, BiolineRX , Eqlibra Medical ,Allium and many more.